Table 1. Nuclear HIF-1α phenotype in bladder tumours in different stages of the disease.
Tumour Stage | Tumour hypoxia based on nuclear HIF-1α | χ2 | |||
---|---|---|---|---|---|
Low | High | Low | High | ||
Ta (15) | 11 (73%) | 4 (27%) | NMIBC | NMIBC | p < 0.05 |
T1 (15) | 6 (40%) | 9 (60%) | 17 (57%) | 13 (43%) | |
T2 (13) | 4 (31%) | 9 (69%) | |||
T3 (15) | 5 (33%) | 10 (67%) | MIBC | MIB C | |
T4 (15) | 3 (20%) | 12 (80%) | 12 (28%) | 31 (72%) | |
Total (73) | 29 (40%) | 44 (60%) |